Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 29, 2016 Filed Jan 17, 2017 21:39 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
GiftCommon Stock 5,754 $0.00 $0.00
Disclosure

SEC source: 0001225208-17-001184 · doc4.xml · nonDerivative · entry 4

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 9,604

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. In a Form 4 filed on May 16, 2016, the Reporting Person reported that 7,769 pre-split shares (15,358 post-split shares) were not beneficially owned by him. The current amount reflected on this Form 4 correctly reflects that such shares are indirectly held by the Reporting Person.

Read SEC document
November 22, 2016 Filed Nov 23, 2016 23:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 49,100 $0.00 Strike: $25.48 $0.00
Disclosure

SEC source: 0001225208-16-042231 · doc4.xml · derivative · entry 7

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Underlying: Common Stock · 49,100 shares

Expires 2017-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F7 · balance_after: Although the balance indicates that there are 5,600 derivative securities beneficially owned following the reported transaction, the correct number should be 294,400. This is a filing software issue which the vendor is working to correct. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 22, 2016 Filed Nov 23, 2016 23:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 25,700 $84.78 $2,178,869.13
Disclosure

SEC source: 0001225208-16-042231 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,637.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F5 · price: This transaction was executed in multiple trades at prices ranging from $84.50 to $85.49. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 22, 2016 Filed Nov 23, 2016 23:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 18,700 $84.18 $1,574,166.00
Disclosure

SEC source: 0001225208-16-042231 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,337.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $83.50 to $84.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 22, 2016 Filed Nov 23, 2016 23:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 4,700 $86.05 $404,424.19
Disclosure

SEC source: 0001225208-16-042231 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,037.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $85.50 to $86.60. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 22, 2016 Filed Nov 23, 2016 23:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 49,100 $25.48 $1,251,068.00
Disclosure

SEC source: 0001225208-16-042231 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,737.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 07, 2016 Filed Nov 8, 2016 22:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 13,650 $0.00 Strike: $44.62 $0.00
Disclosure

SEC source: 0001225208-16-041308 · doc4.xml · derivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,650

Underlying: Common Stock · 13,650 shares

Expires 2018-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 07, 2016 Filed Nov 8, 2016 22:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 13,050 $91.27 $1,191,096.99
Disclosure

SEC source: 0001225208-16-041308 · doc4.xml · nonDerivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,791.5748

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F4 · price: This transaction was executed in multiple trades at prices ranging from $90.71 to $91.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 07, 2016 Filed Nov 8, 2016 22:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 600 $91.71 $55,027.50
Disclosure

SEC source: 0001225208-16-041308 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,841.5748

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F3 · price: This transaction was executed in multiple trades at prices ranging from $91.71 to $91.72. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 07, 2016 Filed Nov 8, 2016 22:27 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 13,650 $44.62 $608,994.75
Disclosure

SEC source: 0001225208-16-041308 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,441.5748

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 21:01 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 20,000 $0.00 Strike: $25.48 $0.00
Disclosure

SEC source: 0001225208-16-041207 · doc4.xml · derivative · entry 7

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,600

Underlying: Common Stock · 20,000 shares

Expires 2017-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 21:01 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
SaleCommon Stock 6,656 $89.15 $593,408.36
Disclosure

SEC source: 0001225208-16-041207 · doc4.xml · nonDerivative · entry 5

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,900.5147

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F5 · price: This transaction was executed in multiple trades at prices ranging from $88.78 to $89.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 21:01 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
SaleCommon Stock 4,919 $91.20 $448,621.16
Disclosure

SEC source: 0001225208-16-041207 · doc4.xml · nonDerivative · entry 4

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,556.5147

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $90.89 to $91.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 21:01 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
SaleCommon Stock 3,325 $90.46 $300,762.88
Disclosure

SEC source: 0001225208-16-041207 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,475.5147

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $89.89 to $90.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 21:01 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
SaleCommon Stock 100 $92.22 $9,222.00
Disclosure

SEC source: 0001225208-16-041207 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,800.5147

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 21:01 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
Exercise / conversionCommon Stock 20,000 $25.48 $509,600.00
Disclosure

SEC source: 0001225208-16-041207 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,900.5147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 01, 2016 Filed Nov 3, 2016 20:22 UTC
Wood Larry LCVP, THV Replacement
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 13,257 $0.00 Strike: $44.62 $0.00
Disclosure

SEC source: 0001225208-16-041101 · doc4.xml · derivative · entry 7

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,258

Underlying: Common Stock · 13,257 shares

Expires 2018-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 01, 2016 Filed Nov 3, 2016 20:22 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 5,457 $92.07 $502,436.36
Disclosure

SEC source: 0001225208-16-041101 · doc4.xml · nonDerivative · entry 5

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,943.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F6 · price: This transaction was executed in multiple trades at prices ranging from $91.60 to $92.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 01, 2016 Filed Nov 3, 2016 20:22 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 3,000 $93.23 $279,675.90
Disclosure

SEC source: 0001225208-16-041101 · doc4.xml · nonDerivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,400.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F5 · price: This transaction was executed in multiple trades at prices ranging from $92.71 to $93.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 01, 2016 Filed Nov 3, 2016 20:22 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 2,700 $94.20 $254,331.63
Disclosure

SEC source: 0001225208-16-041101 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,400.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $93.80 to $94.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 01, 2016 Filed Nov 3, 2016 20:22 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 2,100 $95.25 $200,034.45
Disclosure

SEC source: 0001225208-16-041101 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,100.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $94.81 to $95.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
November 01, 2016 Filed Nov 3, 2016 20:22 UTC
Wood Larry LCVP, THV Replacement
Exercise / conversionCommon Stock 13,257 $44.62 $591,461.06
Disclosure

SEC source: 0001225208-16-041101 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,200.7564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 27, 2016 Filed Oct 29, 2016 00:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 49,100 $0.00 Strike: $25.48 $0.00
Disclosure

SEC source: 0001225208-16-040816 · doc4.xml · derivative · entry 8

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,500

Underlying: Common Stock · 49,100 shares

Expires 2017-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 27, 2016 Filed Oct 29, 2016 00:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 20,099 $91.97 $1,848,422.62
Disclosure

SEC source: 0001225208-16-040816 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,637.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F6 · price: This transaction was executed in multiple trades at prices ranging from $91.32 to $92.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 27, 2016 Filed Oct 29, 2016 00:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 15,900 $92.79 $1,475,291.04
Disclosure

SEC source: 0001225208-16-040816 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,736.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F5 · price: This transaction was executed in multiple trades at prices ranging from $92.33 to $93.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 27, 2016 Filed Oct 29, 2016 00:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 9,101 $93.71 $852,845.61
Disclosure

SEC source: 0001225208-16-040816 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,636.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $93.33 to $94.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 27, 2016 Filed Oct 29, 2016 00:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 4,000 $94.64 $378,574.40
Disclosure

SEC source: 0001225208-16-040816 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,737.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $94.36 to $95.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 27, 2016 Filed Oct 29, 2016 00:13 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 49,100 $25.48 $1,251,068.00
Disclosure

SEC source: 0001225208-16-040816 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,737.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 05, 2016 Filed Oct 6, 2016 20:29 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 13,650 $0.00 Strike: $44.62 $0.00
Disclosure

SEC source: 0001225208-16-040249 · doc4.xml · derivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,300

Underlying: Common Stock · 13,650 shares

Expires 2018-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 05, 2016 Filed Oct 6, 2016 20:29 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 9,950 $119.75 $1,191,479.67
Disclosure

SEC source: 0001225208-16-040249 · doc4.xml · nonDerivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,791.5748

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F4 · price: This transaction was executed in multiple trades at prices ranging from $119.35 to $120.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 05, 2016 Filed Oct 6, 2016 20:29 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 3,700 $120.81 $447,012.91
Disclosure

SEC source: 0001225208-16-040249 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,741.5748

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F3 · price: This transaction was executed in multiple trades at prices ranging from $120.35 to $121.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 05, 2016 Filed Oct 6, 2016 20:29 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 13,650 $44.62 $608,994.75
Disclosure

SEC source: 0001225208-16-040249 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,441.5748

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 23:26 UTC
Wood Larry LCVP, THV Replacement
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 13,257 $0.00 Strike: $44.62 $0.00
Disclosure

SEC source: 0001225208-16-040164 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,515

Underlying: Common Stock · 13,257 shares

Expires 2018-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 23:26 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 12,841 $119.25 $1,531,335.48
Disclosure

SEC source: 0001225208-16-040164 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,943.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $118.70 to $119.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 23:26 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 416 $119.85 $49,858.68
Disclosure

SEC source: 0001225208-16-040164 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,784.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $119.73 to $119.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 23:26 UTC
Wood Larry LCVP, THV Replacement
Exercise / conversionCommon Stock 13,257 $44.62 $591,461.06
Disclosure

SEC source: 0001225208-16-040164 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,200.7564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 14, 2016 Filed Sep 15, 2016 23:52 UTC
Zovighian Bernard JCVP, Surgical Heart Valves
GrantCommon Stock 436 $0.00 $0.00
Disclosure

SEC source: 0001225208-16-039416 · doc4.xml · nonDerivative · entry 1

Zovighian Bernard J · CIK 0001665141 · CVP, Surgical Heart Valves

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,450.0977

F1 · shares: These restricted stock units were granted on September 14, 2016 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.

Read SEC document
September 06, 2016 Filed Sep 7, 2016 20:08 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 13,650 $0.00 Strike: $44.62 $0.00
Disclosure

SEC source: 0001225208-16-038946 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,950

Underlying: Common Stock · 13,650 shares

Expires 2018-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 06, 2016 Filed Sep 7, 2016 20:08 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 13,650 $115.72 $1,579,578.00
Disclosure

SEC source: 0001225208-16-038946 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,791.5748

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 06, 2016 Filed Sep 7, 2016 20:08 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 13,650 $44.62 $608,994.75
Disclosure

SEC source: 0001225208-16-038946 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,441.5748

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2015.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 02, 2016 Filed Sep 6, 2016 21:19 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 20,000 $0.00 Strike: $25.48 $0.00
Disclosure

SEC source: 0001225208-16-038852 · doc4.xml · derivative · entry 4

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,600

Underlying: Common Stock · 20,000 shares

Expires 2017-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F5 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 02, 2016 Filed Sep 6, 2016 21:19 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
SaleCommon Stock 18,000 $115.78 $2,084,049.00
Disclosure

SEC source: 0001225208-16-038852 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,900.5147

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $115.37 to $116.14. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.

Read SEC document
September 02, 2016 Filed Sep 6, 2016 21:19 UTC
BOBO DONALD E JRCVP, Heart Valve Therapy
Exercise / conversionCommon Stock 20,000 $25.48 $509,600.00
Disclosure

SEC source: 0001225208-16-038852 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP, Heart Valve Therapy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,900.5147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 21:18 UTC
Wood Larry LCVP, THV Replacement
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 13,257 $0.00 Strike: $44.62 $0.00
Disclosure

SEC source: 0001225208-16-038851 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,772

Underlying: Common Stock · 13,257 shares

Expires 2018-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 21:18 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 11,742 $115.20 $1,352,624.39
Disclosure

SEC source: 0001225208-16-038851 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,943.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $114.60 to $115.58. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 21:18 UTC
Wood Larry LCVP, THV Replacement
SaleCommon Stock 1,515 $115.81 $175,454.57
Disclosure

SEC source: 0001225208-16-038851 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,685.7564

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $115.71 to $15.985. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 21:18 UTC
Wood Larry LCVP, THV Replacement
Exercise / conversionCommon Stock 13,257 $44.62 $591,461.06
Disclosure

SEC source: 0001225208-16-038851 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, THV Replacement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,200.7564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 21:16 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 49,100 $0.00 Strike: $25.48 $0.00
Disclosure

SEC source: 0001225208-16-038850 · doc4.xml · derivative · entry 6

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,600

Underlying: Common Stock · 49,100 shares

Expires 2017-05-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 21:16 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 44,200 $115.14 $5,089,020.04
Disclosure

SEC source: 0001225208-16-038850 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,637.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F4 · price: This transaction was executed in multiple trades at prices ranging from $114.50 to $115.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 21:16 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 4,900 $115.66 $566,725.67
Disclosure

SEC source: 0001225208-16-038850 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,837.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 28, 2016.

F3 · price: This transaction was executed in multiple trades at prices ranging from $115.50 to $115.94. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.